BISMUSAL - bismuth subsalicylate suspension 
Sparhawk Laboratories, Inc.

Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.

----------

INDICATIONS

A palatable oral suspension for use as an aid in the control of simple diarrhea in cattle, horses and dogs.

CONTRAINDICATIONS

Not recommended for use in cats.

CAUTION

This product contains salicylate; do not administer with other salicylate-containing products, such as aspirin.

DOSAGE AND ADMINISTRATION

Administer orally after the first sign of diarrhea and after each loose bowel movement or as needed.

Dogs--1 to 3 tablespoonfuls
Calves-- 3 to 4 ounces
Foals-- 3 to 4 ounces
Cattle and Horses-- 6-10 fl. ozs.

This product may cause stools to darken. If diarrhea persists after using this product for 2 days, contact a veterinarian.

COMPOSITION

Bismuth Subsalicylate .................. 1.75%
in a palatable aqueous suspension.
Flavoring and coloring added.

FOR ORAL USE ONLY


SHAKE WELL BEFORE USING

Store at room temperature not above 37oC (98.6oF).

Protect from freezing.

TAKE TIME OBSERVE LABEL DIRECTIONS

FOR ANIMAL USE ONLY

KEEP OUT OF REACH OF CHILDREN

NET CONTENTS:
1 GALLON (3.785 L)

ISS. 8-08

Bismusal Suspension Label

BISMUSAL 
bismuth subsalicylate suspension
Product Information
Product TypeOTC ANIMAL DRUGItem Code (Source)NDC:58005-700
Route of AdministrationORALDEA Schedule    
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
BISMUTH SUBSALICYLATE (BISMUTH CATION) BISMUTH SUBSALICYLATE66.2 mg  in 3.785 L
Packaging
#Item CodePackage Description
1NDC:58005-700-073.785 L in 1 JUG
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
unapproved drug other02/18/2009
Labeler - Sparhawk Laboratories, Inc. (147979082)

Revised: 02/2013
Document Id: b4c18dd7-3194-4d60-b2dd-da9ed2e100fd
Set id: d685ed87-5059-4a68-8cfa-2cea2f7ed749
Version: 7
Effective Time: 20130212
 
Sparhawk Laboratories, Inc.